← SynDRA
M4344
SynDRA canonical compound SYN0040132 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | ATR |
|---|
| Mechanism of action | atr kinase inhibitor |
|---|
| Indication | ovarian cancer |
|---|
| Disease area | oncology |
|---|
All known targets
Mechanisms of action (all sources)
- ATR inhibitor
- Serine-protein kinase ATR inhibitor
Cross-references
Synonyms
- Gartisertib
- M-4344
- VX-803
- Butanehydrazide
- Butyrohydrazide
- Butyric acid hydrazide
- Butanohydrazide
- Butyrylhydrazine
- Butanoic acid, hydrazide
- n-Butyric acid hydrazide
- butyric hydrazide
- butanoic acid hydrazide
- FCCCRBDJBTVFSJ-UHFFFAOYSA-N
- butyryl hydrazine
- Butanohydrazide #
- EINECS 222-579-0
- N-butanoyl-hydrazine
- butryic acid hydrazide
- ACMC-1AEKP
- AC1L2SBF
- AC1Q5PVE
- SCHEMBL924945
- Mr-I-33
- ARONIS010643
- SCHEMBL11029887
- CTK3J2024
- DTXSID70188869
- MolPort-000-152-665
- BDBM233138
- NSC41957
- NSC24021
- KS-000041YT
- ALBB-002745
- ZINC1608800
- NSC-240
- Gartisertib [INN]
- 7OM98IUD1O
- VX803
- RefChem:142706
Look up M4344 in the interactive SynDRA portal →